Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

16.21
Delayed Data
As of Feb 08
 -2.02 / -11.08%
Today’s Change
15.70
Today|||52-Week Range
39.90
-47.66%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close18.23
Today’s open17.91
Day’s range15.70 - 18.23
Volume402,943
Average volume (3 months)309,584
Market cap$625.5M
Dividend yield--
Data as of 02/08/2016

Growth & Valuation

Earnings growth (last year)-14,332.99%
Earnings growth (this year)+79.84%
Earnings growth (next 5 years)--
Revenue growth (last year)-17.64%
P/E ratioNM
Price/Sales20.09
Price/Book4.21

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.41+3.38%
TBPHTheravance Biopharma...-0.42-2.41%
ZIOPZIOPHARM Oncology In...-0.17-3.33%
NLNKNewLink Genetics Cor...-2.37-10.20%
Data as of 02/08/2016

Financials

Next reporting dateMarch 17, 2016
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$47.8M
Annual profit (last year)-$38.3M
Net profit margin-80.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers